Literature DB >> 16932575

Surgery insight: Deep brain stimulation for movement disorders.

William S Anderson1, Frederick A Lenz.   

Abstract

Over the past two decades, deep brain stimulation (DBS) has supplanted lesioning techniques for the treatment of movement disorders, and has been shown to be safe and efficacious. The primary therapeutic indications for DBS are essential tremor, dystonia and Parkinson's disease. In the case of Parkinson's disease, DBS is effective for treating the primary symptoms--tremor, bradykinesia and rigidity--as well as the motor complications of drug treatment. Progress has been made in understanding the effects of stimulation at the neuronal level, and this knowledge should eventually improve the effectiveness of this therapy. Preliminary studies also indicate that DBS might be used to treat Tourette's syndrome, obsessive-compulsive disorder, depression and epilepsy. As we will discuss in this review, the success of DBS depends on an appropriate rationale for the procedure, and on collaborations between neurologists and neurosurgeons in defining outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16932575     DOI: 10.1038/ncpneuro0193

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  15 in total

Review 1.  Implantable neurotechnologies: bidirectional neural interfaces--applications and VLSI circuit implementations.

Authors:  Elliot Greenwald; Matthew R Masters; Nitish V Thakor
Journal:  Med Biol Eng Comput       Date:  2016-01-11       Impact factor: 2.602

2.  Thalamic post-inhibitory bursting occurs in patients with organic dystonia more often than controls.

Authors:  K Kobayashi; C C Liu; A L Jensen; J L Vitek; Z Mari; F A Lenz
Journal:  Brain Res       Date:  2013-10-11       Impact factor: 3.252

3.  Integration of pre-aligned liquid metal electrodes for neural stimulation within a user-friendly microfluidic platform.

Authors:  Nicholas Hallfors; Asif Khan; Michael D Dickey; Anne Marion Taylor
Journal:  Lab Chip       Date:  2013-02-21       Impact factor: 6.799

Review 4.  Deep brain stimulation for treatment-resistant depression: a psychiatric perspective.

Authors:  Peter Giacobbe; Sidney H Kennedy
Journal:  Curr Psychiatry Rep       Date:  2006-12       Impact factor: 5.285

5.  Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.

Authors:  Gwenn S Smith; Kelly A Mills; Greg M Pontone; W Stanley Anderson; Kate M Perepezko; James Brasic; Yun Zhou; Jason Brandt; Christopher R Butson; Daniel P Holt; William B Mathews; Robert F Dannals; Dean F Wong; Zoltan Mari
Journal:  Parkinsonism Relat Disord       Date:  2019-04-16       Impact factor: 4.891

6.  The Child & Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation (CHILD-DBS).

Authors:  Han Yan; Lauren Siegel; Sara Breitbart; Carolina Gorodetsky; Hernan D Gonorazky; Ivanna Yau; Cristina Go; Elizabeth Donner; Suneil K Kalia; Alfonso Fasano; Alexander G Weil; Aria Fallah; George M Ibrahim
Journal:  Childs Nerv Syst       Date:  2020-09-15       Impact factor: 1.475

Review 7.  Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies.

Authors:  Takashi Morishita; Kelly D Foote; Adam P Burdick; Yoichi Katayama; Takamitsu Yamamoto; Steven J Frucht; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2009-11-05       Impact factor: 4.891

8.  Selective extracellular stimulation of individual neurons in ganglia.

Authors:  Hui Lu; Cynthia A Chestek; Kendrick M Shaw; Hillel J Chiel
Journal:  J Neural Eng       Date:  2008-08-19       Impact factor: 5.379

9.  Deep brain stimulation of the brainstem.

Authors:  Gavin J B Elias; Aaron Loh; Dave Gwun; Aditya Pancholi; Alexandre Boutet; Clemens Neudorfer; Jürgen Germann; Andrew Namasivayam; Robert Gramer; Michelle Paff; Andres M Lozano
Journal:  Brain       Date:  2021-04-12       Impact factor: 13.501

10.  Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery.

Authors:  Takashi Morishita; Michael S Okun; Adam Burdick; Charles E Jacobson; Kelly D Foote
Journal:  Neuromodulation       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.